Exploratory analysis applied in study of pharmaceutical formulations with piroxicam

Authors

  • Graciele Parisotto Universidade de Santa Cruz do Sul
  • Jorcem Simon de Souza Universidade de Santa Cruz do Sul
  • Marco Flôres Ferrão Universidade de Santa Cruz do Sul; IIIGrupo de Pesquisa em Sistemas e Processos Industriais; Departamento de Informática
  • João Carlos Furtado Universidade de Santa Cruz do Sul; IIIGrupo de Pesquisa em Sistemas e Processos Industriais; Departamento de Informática
  • Rolf Fredi Molz Universidade de Santa Cruz do Sul; IIIGrupo de Pesquisa em Sistemas e Processos Industriais; Departamento de Informática

DOI:

https://doi.org/10.1590/S1516-93322005000400013

Keywords:

Non-steroidal anti-inflammatory drugs (NSAIDs), DRIFTS, Piroxicam, Multivariate analysis, Drugs quality control

Abstract

The identification of different pharmaceutical formulations with piroxicam was studied, using spectra of diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS), in association with hierarchical cluster analysis (HCA) technique. The spectra of samples of the 5 different compounding pharmacies, containing 10 or 20 mg of piroxicam and its respective inactive ingredients, had been collected in Nicolet Magna 550 spectrophotometer. For the multivariate analysis, the spectral information had been processed in software package Pirouette® 2.7 of the Infometrix. The dendograms had been constructed with the autoscaled data, and multiplicative scatter correction (MSC), using three types of linkage methods: single, flexible and incremental. By applying the hierarchical cluster analysis the formation of two distinct groups: one with the active principles and another group with the inactive ingredients was proved. These results demonstrate that the DRIFTS associated with chemometrics tools, constitute a quality control alternative of drugs production processes.

Downloads

Download data is not yet available.

Published

2005-12-01

Issue

Section

Original Papers

How to Cite

Exploratory analysis applied in study of pharmaceutical formulations with piroxicam. (2005). Revista Brasileira De Ciências Farmacêuticas, 41(4), 499-505. https://doi.org/10.1590/S1516-93322005000400013